Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
6,144
datasets available to search
ShareScore release 0.9.0
Dataset results
6,144 results for “cancer treatment”
An Observational Study on Bevacizumab (Avastin) as First-Line Treatment in Colorectal Cancer Participants With Potentially Resectable Liver Metastases
ClinicalTrials.gov study NCT01343901. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Transitions Project: Supporting Adults During the Shift From Cancer Treatment to Surveillance
ClinicalTrials.gov study NCT04450043. IPD Sharing: YES. Countries: 1. Publications: 0.
Study of Safety and Tolerability of PCI-27483 in Patients With Pancreatic Cancer Patients Receiving Treatment With Gemcitabine
ClinicalTrials.gov study NCT01020006. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ramucirumab and Pembrolizumab Versus Standard of Care in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Non-Match Treatment Trial)
ClinicalTrials.gov study NCT03971474. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety of AMG 706 Plus Panitumumab Plus Chemotherapy in the Treatment of Subjects With Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT00101894. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Pembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder Cancer
ClinicalTrials.gov study NCT04383743. IPD Sharing: NO. Countries: 1. Publications: 0.
LMB-100 Followed by Pembrolizumab in the Treatment of Adults With Mesothelin-Expressing Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT04027946. IPD Sharing: YES. Countries: 1. Publications: 0.
Study of Aflibercept as Maintenance Therapy Following Induction With Aflibercept in Combination With XELOX, as First-Line Treatment for Metastatic Colorectal Cancer Patient
ClinicalTrials.gov study NCT01955629. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Using E-Nose Technology to Track Treatment Response in People With Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT07218601. IPD Sharing: YES. Countries: 1. Publications: 0.
Effect of Healing Touch on the Experience of Women Undergoing Treatment for Breast Cancer
ClinicalTrials.gov study NCT00533780. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Multimodality Treatment for Patients With Resectable Non-Small Cell Lung Cancer (NSCLC) - BEACON Study: Bevacizumab and Chemotherapy for Operable NSCLC
ClinicalTrials.gov study NCT00130780. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Testing Copanlisib as Potentially Targeting Treatment in Cancers With PTEN Loss (MATCH - Subprotocol Z1G)
ClinicalTrials.gov study NCT06360588. IPD Sharing: YES. Countries: 1. Publications: 0.
Testing Whether Cancers With Specific Mutations Respond Better to Glutaminase Inhibitor, Telaglenastat Hydrochloride, Anti-Cancer Treatment, BeGIN Study
ClinicalTrials.gov study NCT03872427. IPD Sharing: YES. Countries: 1. Publications: 0.
Temozolomide for Treatment of Brain Metastases From Non-Small Cell Lung Cancer (Study P03247)
ClinicalTrials.gov study NCT00076856. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Anaplastic Lymphoma Kinase (ALK)-Positive Non-small Cell Lung Cancer (NSCLC) Post-alectinib Treatment Patterns
ClinicalTrials.gov study NCT04351334. IPD Sharing: NO. Countries: 1. Publications: 0.
FOLFIRI Versus Irinotecan as Second-line Treatment in Metastatic Colorectal Cancer Patients
ClinicalTrials.gov study NCT02935764. IPD Sharing: Not stated. Countries: 0. Publications: 1.
A Safety, Pharmacokinetic and Efficacy Study of NUC-3373 in Combination With Standard Agents Used in Colorectal Cancer Treatment
ClinicalTrials.gov study NCT03428958. IPD Sharing: NO. Countries: 3. Publications: 0.
Testing Afatinib as Potentially Targeted Treatment in Cancers With EGFR Genetic Changes (MATCH - Subprotocol A)
ClinicalTrials.gov study NCT06385483. IPD Sharing: YES. Countries: 1. Publications: 0.
An Observational Study of Adjuvant Treatment With Capecitabine (Xeloda) in Combination With Oxaliplatin in Participants With Stage III Colon Cancer
ClinicalTrials.gov study NCT01442155. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open Label Trial of Afatinib (Giotrif) in Treatment-naive (1st Line) or Chemotherapy Pre-treated Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Harboring EGFR Mutat
ClinicalTrials.gov study NCT01853826. IPD Sharing: YES. Countries: 11. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.